Michele Fogliata | Medicine and Dentistry | Excellence in Research Award

Published on by Global Scholar Awards

Mr. Michele Fogliata | Medicine and Dentistry | Excellence in Research Award

Ospedale Manzoni di lecco | Italy

Mr. Fogliata, Michele is a clinical researcher affiliated with Fondazione IRCCS San Gerardo dei Tintori, specializing in general surgery and perioperative care. He has authored 3 scientific publications, receiving 38 citations with an h-index of 2, reflecting a focused and emerging research profile. His work emphasizes enhanced recovery protocols in emergency surgery, contributing to improved patient outcomes and evidence-based clinical practices. With extensive collaboration across multidisciplinary teams, he actively supports clinical research integration into healthcare systems. His contributions highlight a commitment to advancing surgical efficiency, optimizing recovery pathways, and enhancing the quality of patient-centered care in modern medical practice.

Citation Metrics (Scopus)

38
30
20
10
0

Citations

38

Documents

3

h-index

2

Citations

Documents

h-index

View Scopus Profile

Featured Publication


Adherence to enhanced recovery protocol in emergency general surgery: A prospective observational study
– Ceresoli, M., Fumagalli, C., Rettani, A., et al. (2025), Updates in Surgery

Kenjiro Nagai | Respiratory | Research Excellence Award

Published on by Global Scholar Awards

Prof. Dr. Kenjiro Nagai | Respiratory | Research Excellence Award

Chairman | Ebino centro Clinic | Research Excellence Award

Dr. Nagai, Kenjiro is a clinician–researcher affiliated with Ebino Sentoro Clinic, Japan, specializing in infectious diseases, immunotherapy, and respiratory disorders, particularly virus-associated pulmonary complications. He has authored 19 Scopus-indexed publications and received over 565 citations, achieving an h-index of 11, which reflects sustained academic influence and research quality. With 41 co-authors, he maintains active multidisciplinary collaborations that enhance translational and clinical research outcomes. Among his notable contributions is an open-access case report published in BMJ Case Reports examining amplified natural killer cell therapy for HTLV-1–associated bronchiolitis and alveolar abnormalities. His work emphasizes innovative, evidence-based, and patient-centered therapeutic strategies. Through clinical scholarship, collaborative engagement, and translational application of immunotherapeutic approaches, Dr. Nagai contributes meaningfully to improving treatment outcomes and advancing global understanding of complex infectious and immune-mediated diseases.

Citation Metrics (Scopus)

565
400
300
150
0

Citations

565

Documents

19

h-index

11

Citations

Documents

h-index

View Scopus Profile

Featured Publication

Daulet Berikbol | Oncology | Scientific Advancement Achievement Award

Published on by Global Scholar Awards

Dr. Daulet Berikbol | Oncology | Scientific Advancement Achievement Award

UMIT International Oncology Center for Tomotherapy, LLP | Kazakhstan

Dr. Berikbol Daulet is a medical researcher at the UMIT International Oncological Center of Tomotherapy, Astana, Kazakhstan, with expertise in radiation oncology, tomotherapy, and advanced cancer treatment strategies. His research focuses on integrating precision radiotherapy with immunological and cellular therapies to improve outcomes in complex and advanced-stage cancers. He has authored 4 peer-reviewed publications, received 2 citations, and holds an h-index of 1, reflecting focused and emerging contributions to clinical oncology. Dr. Daulet actively engages in multidisciplinary clinical and translational research, contributing to collaborative studies that bridge radiotherapy and immunotherapy. His recent open-access case report on combined tomotherapy and autologous peripheral-blood–derived lymphocyte infusion for stage IIIa lung cancer highlights innovative, patient-centered treatment approaches, particularly for elderly patients. Through applied clinical research, he supports evidence-based oncology practice, advances modern cancer treatment technologies, and contributes to improved patient outcomes and broader societal benefit in healthcare.

Citation Metrics (Scopus)

4
3
2
1
0

Citations

2

Documents

4

h-index

1

Citations

Documents

h-index

View Scopus Profile View ORCID Profile

Featured Publications

Elroy Patrick Weledji | Medicine and Dentistry | Research Excellence Award

Published on by Global Scholar Awards

Prof. Dr. Elroy Patrick Weledji | Medicine and Dentistry | Research Excellence Award

Professor of Surgery | University of Buea | Cameroon

Dr. Elroy Patrick Weledji is a clinician–researcher at the University of Buea, Cameroon, with recognized expertise in general surgery, trauma care, and perioperative management, particularly within resource-limited settings. He has authored 62 peer-reviewed publications, receiving over 792 citations, with an h-index of 14, reflecting sustained scholarly impact. His research spans guideline implementation in colorectal surgery, appendicitis management, complex trauma and orthopedic stabilization, and clinically relevant surgical reviews, with multiple open-access contributions enhancing global knowledge dissemination. Dr. Weledji has collaborated with an extensive international network of more than 180 co-authors, demonstrating strong interdisciplinary and cross-regional engagement. His work emphasizes evidence-based practice, pragmatic surgical solutions, and health system improvement, contributing meaningfully to patient outcomes, surgical education, and the advancement of equitable healthcare delivery in low- and middle-income countries.

Citation Metrics (Scopus)

792
600
400
200
0

Citations

792

Documents

62

h-index

14

Citations

Documents

h-index

View Scopus Profile
 View ORCID Profile
 View ResearchGate Profile

Featured Publications

Lijie Ma | Liver Immunology | Research Excellence Award

Published on by Global Scholar Awards

Dr. Lijie Ma | Liver Immunology | Research Excellence Award

Renji Hospital Shanghai Jiao Tong University School of Medicine | China

Dr. Lijie Ma is a clinician-scientist at Fudan University, Shanghai, China, with recognized expertise in surgical oncology, particularly in the management of retroperitoneal sarcoma, hepatobiliary tumors, and complex oncologic surgery. His scholarly work is widely cited and demonstrates sustained influence in high-impact surgical and medical journals. Dr. Ma’s research emphasizes multidisciplinary care models, outcome-driven surgical strategies, and translational approaches, including single-cell analysis, to better understand tumor progression and metastatic mechanisms. He is an active participant in extensive national and international collaborations, contributing to the development of standardized, evidence-based clinical practices. Through the integration of advanced research methodologies and real-world clinical data, Dr. Ma’s work supports improved patient care, optimized surgical outcomes, and meaningful advances in modern cancer management with broad societal relevance.

Citation Metrics (Scopus)

2866
2200
1600
800
0

Citations

2,866

Documents

43

h-index

26

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Sakarie Mustafe Hidig | Health Professions | Editorial Board Member

Published on by Global Scholar Awards

Prof. Sakarie Mustafe Hidig | Health Professions | Editorial Board Member

Assistant Professor | Zhejiang University School of Medicine | China

Sakarie Mustafe Hidig is a researcher at Zhejiang University, Hangzhou, China, specializing in biomaterials, drug delivery systems, and immunotherapeutic strategies for cancer treatment. His research focuses on the design of functional polymer-based platforms particularly chitosan hydrogels and boronated diol drug conjugates aimed at enhancing therapeutic efficacy while stimulating robust anti-tumor immune responses. His recent work on a versatile chitosan hydrogel for hepatocellular carcinoma demonstrates a powerful fusion of material science and immune engineering, offering new avenues for more effective and biocompatible cancer therapies. Dr. Hidig has authored 7 peer-reviewed publications, earning 12 citations and maintaining an h-index of 2, reflecting his early but steadily increasing scholarly impact. With collaborations spanning 27 international co-authors, he engages actively in multidisciplinary research that advances innovative, targeted, and safer therapeutic solutions. His contributions address global health priorities by developing responsive materials capable of improving clinical outcomes, reducing toxicity, and shaping the future landscape of cancer treatment technologies.

Profiles: Scopus | ORCID

Featured Publications

1. Hidg, S. M., & Samatar, H. (2025). Optimal timing of percutaneous transhepatic gallbladder drainage in high-risk acute cholecystitis patients and its impact on elective laparoscopic cholecystectomy. RGUHS Journal of Medical Sciences, 15(1), 32–42.

2. Fatima, B., Rubab, N., Mujahid, M. U. F. M., & Hidig, S. M. (2025). A large pediatric retroperitoneal benign lipoma in a 2-year-old female: A case report and literature review. Medicine, December 5, 2025.

3. Hidig, S. M., Mujahid, M. U. F. M., Jie, Y., & Hu, Z. (2025). Status epilepticus and stethoscopes: The struggle and strategy of doctors in the management of status epilepticus in long-term modern warfare conflict settings. Epileptic Disorders, 2025.

4. Yang, S., Zhang, E., Li, Z., Long, Y., Li, Y., Zhang, J., Wang, F., Liu, L., Wang, T., Guo, J., & Hou, Z. (2025). Deep vein thrombosis in patients with patellar fractures: Assessing incidence rates and identifying risk factors. PLOS ONE, 20(2), e0316628.

5. Hidig, S. M., Kakule Kitaghenda, F., & Samatar, H. (2025). Assessing the role of Helicobacter pylori in cholelithiasis development: A meta-analytical approach. Greenfort International Journal of Applied Medical Science, 3(01), Article 004.

Gwendolyn Quinn | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Gwendolyn Quinn | Medicine and Dentistry | Best Researcher Award

Professor| New York University| United States

Dr. Gwendolyn P. Quinn is an internationally recognized behavioral scientist and bioethicist whose research focuses on patient–provider communication, reproductive ethics, and quality of life among cancer patients, particularly adolescents, young adults, and sexual and gender minority populations. She is Professor and Vice Chair of Research in the Departments of Obstetrics and Gynecology and Population Health at the New York University Grossman School of Medicine, where she also holds the Livia Wan Endowed Chair and is a member of the Division of Medical Ethics and the Perlmutter Cancer Center. Dr. Quinn’s work integrates behavioral science, ethics, and public health to enhance communication about reproductive health, genetics, and fertility preservation for individuals undergoing gonadotoxic treatment. She directs the NCI-funded ENRICH/ECHO training program, which improves oncology providers’ communication skills in reproductive and genetic health, and has contributed to national and international guidelines for ASCO, ASRM, and the PANCARE Life consortium. With more than 450 peer-reviewed publications—approximately 300 focused on reproductive health and bioethics—Dr. Quinn has significantly influenced research and practice in oncofertility, ethics, and cancer survivorship. She has served on the Board of Scientific Counselors for the National Institute of Environmental Health Sciences and holds fellowships in the American Association for Cancer Education and the New York Academy of Medicine. Her numerous honors, including the American Psychosocial Oncology Society’s Outstanding Education and Training Award, reflect her sustained leadership and impact on advancing equitable reproductive health care, ethical medical practice, and the education of future generations of researchers and clinicians worldwide.

Profiles: Google Scholar |Scopus | ORCID

Featured Publications

Loren, A. W., Mangu, P. B., Beck, L. N., Brennan, L., Magdalinski, A. J., Partridge, A. H., … & Quinn, G. P. (2013). Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. Journal of Clinical Oncology, 31(19), 2500–2510. Cited by: 1,901

Oktay, K., Harvey, B. E., Partridge, A. H., Quinn, G. P., Reinecke, J., Taylor, H. S., … & Loren, A. W. (2018). Fertility preservation in patients with cancer: ASCO clinical practice guideline update. Journal of Clinical Oncology, 36(19), 1994–2001. Cited by: 1,663

Quinn, G. P., Sanchez, J. A., Sutton, S. K., Vadaparampil, S. T., Nguyen, G. T., Green, B. L., … & Schabath, M. B. (2015). Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA: A Cancer Journal for Clinicians, 65(5), 384–400. Cited by: 551

Quinn, G. P., Vadaparampil, S. T., Lee, J. H., Jacobsen, P. B., Bepler, G., Lancaster, J., & Keefe, D. L. (2009). Physician referral for fertility preservation in oncology patients: A national study of practice behaviors. Journal of Clinical Oncology, 27(35), 5952–5957. Cited by: 490

Nahata, L., Tishelman, A. C., Caltabellotta, N. M., & Quinn, G. P. (2017). Low fertility preservation utilization among transgender youth. Journal of Adolescent Health, 61(1), 40–44. Cited by: 345

 

Dr. Gwendolyn P. Quinn’s pioneering work in reproductive ethics, patient–provider communication, and oncofertility has transformed clinical practice and education worldwide, advancing equitable reproductive health care for cancer patients and sexual and gender minorities. Her research and training initiatives have shaped global guidelines and strengthened ethical, compassionate communication in medicine.

Chizaram Onyeaghala | Infectious Diseases | Best Researcher Award

Published on by Global Scholar Awards

Dr. Chizaram Onyeaghala | Infectious Diseases | Best Researcher Award

Consultant Physician | University of Port Harcourt Teaching Hospital | Nigeria

Dr. Chizaram A. Onyeaghala is a Consultant Physician and Infectious Diseases Specialist at the University of Port Harcourt Teaching Hospital, Nigeria. His expertise lies in infectious diseases, HIV medicine, emerging and re-emerging infections, and global health. With a strong academic foundation, he holds qualifications from prestigious institutions, including the West African College of Physicians, the National Postgraduate Medical College of Nigeria, and advanced certifications in Vaccinology, Genomics, and Global Health from Stellenbosch University, Liverpool John Moores University, and the Royal College of Physicians, London. Dr. Onyeaghala’s research portfolio reflects a robust engagement with global health challenges. His works, cited over 837 times with an h-index of 11 and i10-index of 12, have been published in top-tier journals such as The Lancet Infectious Diseases, European Respiratory Journal, and Clinical Infectious Diseases. His collaborations with renowned institutions, including the University of Alabama at Birmingham, Queen Mary University of London, and Washington University in St. Louis, underscore his commitment to international scientific partnership and multidisciplinary inquiry. He has contributed to several landmark studies on Mpox, COVID-19, tuberculosis, antimicrobial resistance, and Lassa fever, which have informed clinical practice and public health response strategies in Nigeria and beyond. As a lead clinician in WHO- and LSTM-funded studies, and a member of national technical working groups, his research and leadership have had tangible societal impact—enhancing epidemic preparedness, infection prevention, and community health resilience. Dr. Onyeaghala’s professional engagements extend to editorial and review roles for international journals and active membership in organizations such as IDSA, IAS, ESCMID, and NIDS. His growing scholarly influence, mentorship activities, and policy-driven research continue to strengthen global infectious disease control and scientific innovation.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Mitjà, O., Alemany, A., Marks, M., Mora, J. I. L., Rodríguez-Aldama, J. C., Silva, M. S. T., Onyeaghala, C. A., et al. (2023). Mpox in people with advanced HIV infection: A global case series. The Lancet, 401(10380), 939–949. https://doi.org/10.1016/S0140-6736(23)00273-3 — Citations: 480

  2. Ogoina, D., Dalhat, M. M., Denue, B. A., Okowa, M., Chika-Igwenyi, N. M., Onyeaghala, C. A., et al. (2023). Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: A cohort study. The Lancet Infectious Diseases, 23(12), 1418–1428. https://doi.org/10.1016/S1473-3099(23)00409-7 — Citations: 49

  3. Global Tuberculosis Network, Casco, N., Jorge, A. L., Palmero, D. J., Alffenaar, J. W., Fox, G. J., Onyeaghala, C. A., et al. (2023). Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort. European Respiratory Journal, 62(5). https://doi.org/10.1183/13993003.00925-2023 — Citations: 45

  4. Migliori, G. B., Visca, D., van den Boom, M., Tiberi, S., Silva, D. R., Centis, R., Onyeaghala, C. A., et al. (2021). Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence. Pulmonology, 27(3), 248–256. https://doi.org/10.1016/j.pulmoe.2020.12.016 — Citations: 41

  5. Haeuser, E., Byrne, S., Nguyen, J., Raggi, C., McLaughlin, S. A., Bisignano, C., Onyeaghala, C. A., et al. (2025). Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: A systematic analysis for the Global Burden of Disease Study. The Lancet. — Citations: 26

Aylin Köseler | Medicine | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Aylin Köseler | Medicine | Best Researcher Award

Professor | Pamukkale University Medical Faculty | Turkey

Professor Aylin Köseler is a distinguished academic in the field of biophysics and molecular genetics, currently serving in the Department of Biophysics at Pamukkale University Faculty of Medicine. Her extensive research career spans over two decades, focusing on the molecular mechanisms underlying genetic variability, pharmacogenomics, and disease susceptibility. She has made significant contributions to understanding gene–environment interactions, genetic polymorphisms, and epigenetic regulations associated with cardiovascular diseases, metabolic disorders, and infectious diseases such as COVID-19. Prof. Köseler has led and participated in numerous national and international research projects, including collaborations with prestigious institutions such as Harvard Medical School and the University of California, Los Angeles (UCLA). Her notable involvement in projects like Whole Genome Sequencing of Ancient DNA and Epigenetics in Identical Twins and COVID-19 Patients demonstrates her commitment to interdisciplinary science bridging genetics, biophysics, and clinical medicine. Throughout her academic tenure, she has supervised graduate research and contributed to advancing biomedical science through experimental and computational biophysics approaches. She has authored and co-authored numerous peer-reviewed publications and presented her work at scientific conferences worldwide. Her research outputs have been recognized for their scientific rigor and impact on personalized medicine, population genetics, and evolutionary biology. Beyond academic excellence, Prof. Köseler’s work has substantial societal implications, particularly in improving diagnostic precision, therapeutic efficacy, and public health outcomes. Her dedication to fostering young researchers and promoting collaborative innovation underscores her leadership in the Turkish and international scientific communities. Her ongoing projects continue to explore genetic determinants of complex diseases and epigenetic modulation, contributing valuable insights to the global biomedical research landscape.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Sabirli, R., Köseler, A., Goren, T., Turkcuer, I., & Kurt, O. (2021). High GRP78 levels in COVID-19 infection: A case-control study. Life Sciences, 265, 118781. https://doi.org/10.1016/j.lfs.2020.118781 — Cited by: 128

  2. Palmeira, A., Sousa, E., Köseler, A., Sabirli, R., Gören, T., Türkçüer, İ., Kurt, Ö., et al. (2020). Preliminary virtual screening studies to identify GRP78 inhibitors which may interfere with SARS-CoV-2 infection. Pharmaceuticals, 13(6), 132. https://doi.org/10.3390/ph13060132 — Cited by: 77

  3. Köseler, A., Sabirli, R., Gören, T., Türkçüer, İ., & Kurt, Ö. (2020). Endoplasmic reticulum stress markers in SARS-CoV-2 infection and pneumonia: Case-control study. In Vivo, 34(3 Suppl), 1645–1650. https://doi.org/10.21873/invivo.11938 — Cited by: 75

  4. Akca, H., Demiray, A., Yaren, A., Bir, F., Koseler, A., Iwakawa, R., Bagci, G., et al. (2013). Utility of serum DNA and pyrosequencing for the detection of EGFR mutations in non-small cell lung cancer. Cancer Genetics, 206(3), 73–80. https://doi.org/10.1016/j.cancergen.2013.05.012 — Cited by: 58

  5. Atalay, E. Ö., Koyuncu, H., Turgut, B., Atalay, A., Yildiz, S., Bahadir, A., & Köseler, A. (2005). High incidence of Hb D-Los Angeles [β121 (GH4) Glu→ Gln] in Denizli Province, Aegean region of Turkey. Hemoglobin, 29(4), 307–310. https://doi.org/10.1080/03630260500217438 — Cited by: 50

Kyung Jun Heo | Reconstructive Surgery | Best Researcher Award

Published on by Global Scholar Awards

Dr. Kyung Jun Heo | Reconstructive Surgery | Best Researcher Award

Resident | Kyung Hee University | South Korea

Dr. Kyung Jun Heo, M.D., is a dedicated clinician-scientist in the field of plastic and reconstructive surgery, currently serving as a Resident at the Department of Plastic and Reconstructive Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. He completed his B.S. in Medical Science at Kyung Hee University in 2014, followed by his M.D. from Chung-Ang University College of Medicine in 2019. Professionally, he has served as a Public Health Doctor at Anseong City Public Health Center (2019–2022), where he played a critical role as an epidemiological investigator during the COVID-19 pandemic and as an adverse events following immunization (AEFI) surveillance officer. His clinical and research interests span microsurgical reconstruction, particularly super-thin ALT and DIEP flaps for complex reconstructions, aesthetic and anti-aging medicine with a focus on collagen stimulators and fillers, and wound healing and scar biology, including keloid research and the role of α7 nicotinic acetylcholine receptor agonists. He has co-authored impactful publications, including work in Biomaterials (2012) and a recent article on the anti-fibrotic effects of α7nAChR agonists in keloid fibroblasts (2025), alongside multiple conference presentations at the Korean Society of Plastic and Reconstructive Surgeons (KSPRS) international congresses. His research skills include clinical trial design, microsurgical techniques, translational wound healing studies, and collaborative projects that bridge clinical innovation with molecular biology. Though early in his career, Dr. Heo has demonstrated leadership through both community service and academic engagement, supported by certifications in medicine and Basic Life Support. With 145 citations by 145 documents, 1 document indexed, and an h-index of 1, his academic footprint is steadily expanding. Driven by a commitment to advancing reconstructive techniques and improving patient outcomes, Dr. Heo shows strong promise for future contributions in high-impact research, international collaboration, and academic leadership, making him a valuable asset to the global medical research community.

Profiles: Scopus | ORCID 

Featured Publication

Jung, H. S., Pradhan, T., Han, J. H., Heo, K. J., Lee, J. H., Kang, C., & Kim, J. S. (2012). Molecular modulated cysteine-selective fluorescent probe. Biomaterials, 33(33), 8495–8502. Citations: ~ 143